Quoin Pharmaceuticals announces FDA rare pediatric designation for QRX003
QNRX correction: Quoin Pharmaceuticals said the FDA granted rare pediatric disease designation for QRX003 in peeling skin syndrome.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.